REBECCA ROHRS: Open Payments
NPI 1831295898 · FLORESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 50 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $487 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $392 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $171 |
| Madrigal Pharmaceuticals | 9 | $151 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Janssen Biotech, Inc. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 3 | $58 |
| Ardelyx, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $21 |
| EVOKE PHARMA, INC. | 1 | $19 |
Products named: ENTYVIO, CREON, REZDIFFRA, RINVOQ, VOQUEZNA, LINZESS, TREMFYA, ZENPEP.
Industry payments across TX — which companies pay providers there.
